3706-38-5 Usage
Uses
Used in Pharmaceutical Research:
DL-P-CHLOROAMPHETAMINE HYDROCHLORIDE is used as a research compound for studying the effects of monoamine releasers on the central nervous system. Its application in this field aids in understanding the mechanisms of action and potential therapeutic uses of similar compounds.
Used in Neurochemical Studies:
DL-P-CHLOROAMPHETAMINE HYDROCHLORIDE is used as a neurochemical tool for investigating the roles of serotonin and dopamine in various neurological and psychiatric conditions. This application helps researchers gain insights into the underlying causes and potential treatment options for these conditions.
Used in Toxicology Research:
DL-P-CHLOROAMPHETAMINE HYDROCHLORIDE is used as a toxicological agent to study the effects of high neurotoxicity on the brain and nervous system. This application is crucial for developing strategies to mitigate the harmful effects of neurotoxic substances and improve the safety of drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 3706-38-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,7,0 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 3706-38:
(6*3)+(5*7)+(4*0)+(3*6)+(2*3)+(1*8)=85
85 % 10 = 5
So 3706-38-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H12ClN.ClH/c1-7(11)6-8-2-4-9(10)5-3-8;/h2-5,7H,6,11H2,1H3;1H
3706-38-5Relevant academic research and scientific papers
Method of treating nausea and vomiting with certain substituted-phenylalkylamino (and aminoacid) derivatives and other serotonin depleting agents
-
, (2008/06/13)
A method for the treatment of emesis in a mammal, which method comprises administering to said mammal an emesis inhibiting amount of a compound which depletes serotonin in the brain of mammals; among which are compounds having the formula: STR1 wherein, R is selected from hydrogen, loweralkyl, trifluoromethyl, carboxyl, or loweralkoxycarbonyl; R1 and R2 are hydrogen or loweralkyl; Z is trifluoromethyl or halogen; the optical isomers and pharmaceutically acceptable salts thereof; two of the preferred compounds of the invention are fenfluramine and norfenfluramine.